4//SEC Filing
Meggs Jason M. 4
Accession 0001209191-22-016384
CIK 0001610950other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:08 PM ET
Size
10.3 KB
Accession
0001209191-22-016384
Insider Transaction Report
Form 4
Meggs Jason M.
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2022-03-02+9,364→ 63,853 total - Award
Class A Common Stock
2022-03-02+2,323→ 66,176 total - Award
Class A Common Stock
2022-03-02+2,513→ 68,689 total - Tax Payment
Class A Common Stock
2022-03-02$80.75/sh−6,453$521,080→ 62,236 total
Footnotes (3)
- [F1]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021.
- [F2]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2022, subject to continued employment.
- [F3]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment.
Documents
Issuer
Syneos Health, Inc.
CIK 0001610950
Entity typeother
Related Parties
1- filerCIK 0001660670
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:08 PM ET
- Size
- 10.3 KB